Gotowa bibliografia na temat „MS – Multiple Sclerosis”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „MS – Multiple Sclerosis”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "MS – Multiple Sclerosis"
Mazziotti, Valentina. "Pregnancy in Multiple Sclerosis." Archives of Case Reports: Open Access 1, no. 1 (2024): 01–04. http://dx.doi.org/10.33140/acroa.01.01.01.
Pełny tekst źródłaArtur Medina, Jose. "Multiple Sclerosis and Chlamydia." International Journal of Clinical Case Reports and Reviews 9, no. 1 (2021): 01–02. http://dx.doi.org/10.31579/2690-4861/163.
Pełny tekst źródłaS, P. SRINIVAS NAYAK, Tabassum Javeriya, and Naaz Mahjabeen. "Management of Multiple Sclerosis and Effectiveness of Ozanimod in Relapsing Multiple Sclerosis." Management of Multiple Sclerosis and Effectiveness of Ozanimod in Relapsing Multiple Sclerosis 3, no. 6 (2020): 67–73. https://doi.org/10.5281/zenodo.5469941.
Pełny tekst źródłaeyedaghanoor, Sadegh. "How to Heal Patient with Multiple Sclerosis." Journal of Biomedical Research & Environmental Sciences 2, no. 6 (2021): 523–24. https://doi.org/10.37871/jbres1269.
Pełny tekst źródłaBudimkić, Maja, Olivera Tamaš, Nikola Veselinović, Šarlota Mesaroš, and Jelena Drulović. "Late onset multiple sclerosis." Medicinski podmladak 75, no. 5 (2024): 48–57. https://doi.org/10.5937/mp75-52391.
Pełny tekst źródłaRohani, Mohammad, and Shadi Ghourchian. "Fulminant multiple sclerosis (MS)." Neurological Sciences 32, no. 5 (2011): 953–57. http://dx.doi.org/10.1007/s10072-011-0723-0.
Pełny tekst źródłaAlroughani, Raed, and Bassem Yamout. "Multiple Sclerosis." Seminars in Neurology 38, no. 02 (2018): 212–25. http://dx.doi.org/10.1055/s-0038-1649502.
Pełny tekst źródłaEric, Theodore, and Bates Archer. "Multiple Sclerosis: A Systemic Review of Drugs and Therapeutics." Neuroscience and Neurological Surgery 1, no. 3 (2017): 01–03. http://dx.doi.org/10.31579/2578-8868/018.
Pełny tekst źródłaCanto, Ester, and Jorge R. Oksenberg. "Multiple sclerosis genetics." Multiple Sclerosis Journal 24, no. 1 (2018): 75–79. http://dx.doi.org/10.1177/1352458517737371.
Pełny tekst źródłaAlbatineh, Ahmed N., Raed Alroughani, and Rabeah Al-Temaimi. "Predictors of Multiple Sclerosis Severity Score in Patients with Multiple Sclerosis." International Journal of MS Care 22, no. 5 (2020): 233–38. http://dx.doi.org/10.7224/1537-2073.2019-054.
Pełny tekst źródłaRozprawy doktorskie na temat "MS – Multiple Sclerosis"
Foley, Peter Leonard. "Pain in multiple sclerosis." Thesis, University of Edinburgh, 2017. http://hdl.handle.net/1842/28949.
Pełny tekst źródłaCraig, Charles J. "Studies of immunoregulation in Multiple Sclerosis." Thesis, Queen's University Belfast, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.328088.
Pełny tekst źródłaEvangelou, N. "Approaches to defining axonal loss in multiple sclerosis." Thesis, University of Oxford, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.249538.
Pełny tekst źródłaThannhauser, Jennifer, and University of Lethbridge Faculty of Education. "The psychosocial experiences of individuals diagnosed with early-onset MS." Thesis, Lethbridge, Alta. : University of Lethbridge, Faculty of Education, 2005, 2005. http://hdl.handle.net/10133/284.
Pełny tekst źródłaBrown, Nolan J. "Localization of hemoglobin in MS cortex and its relevance to MS neuropathology." Kent State University Honors College / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=ksuhonors1399400834.
Pełny tekst źródłaRogers, Stephen. "Glycosylation of immunoglobulin G in cerebrospinal fluid and multiple sclerosis." Thesis, University of Surrey, 2001. http://epubs.surrey.ac.uk/843781/.
Pełny tekst źródłaIacobaeus, Ellen. "Establishment and applications of a multiple sclerosis biobank analysis of biomarkers and therapeutic complications in MS /." Stockholm, 2010. http://diss.kib.ki.se/2010/978-91-7409-811-2/.
Pełny tekst źródłaMann, C. L. A. "The relationship of genetic polymorphisms to disease severity of multiple sclerosis." Thesis, Keele University, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.341244.
Pełny tekst źródłaThummala, Suneel K. "Axon Initial Segment Stability in Multiple Sclerosis." VCU Scholars Compass, 2015. http://scholarscompass.vcu.edu/etd/4038.
Pełny tekst źródłaRaask, Pontus, and Oskar Salomonsson. "Att leva med MS : En studie av självbiografier." Thesis, University of Skövde, School of Life Sciences, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-1080.
Pełny tekst źródłaKsiążki na temat "MS – Multiple Sclerosis"
Jones, Christian. MS: My story. Artshare South West (Cornwall) in conjunction with The Multiple Sclerosis Society of Great Britain and Northern Ireland (Mid-Cornwall Branch), 1989.
Znajdź pełny tekst źródłaHarrold, Kimberly. Sometimes MS is yucky. Science & Humanities Press, 2005.
Znajdź pełny tekst źródłaMcLaughlin, Chris. Multiple sclerosis: A positive approach to living with MS. Bloomsbury, 1997.
Znajdź pełny tekst źródłaT, Fraser Robert, ed. The MS workbook: Living fully with multiple sclerosis. New Harbinger Publications, 2005.
Znajdź pełny tekst źródłaDevine, Monique. How to talk about ms with your children: A guide for parents. Multiple Sclerosis Society of Ireland, 2003.
Znajdź pełny tekst źródłaEerdekens, Jeanine. Chronische ziekte en rolverandering: Een sociologisch onderzoek bij MS-patiënten. Acco, 1989.
Znajdź pełny tekst źródłaSahraian, M. A. (Mohammad Ali) and SpringerLink (Online service), eds. MRI Atlas of MS Lesions. Springer-Verlag, 2008.
Znajdź pełny tekst źródłaRomberg, Anders. MS ja liikunta: Iloa, elämänlaatua, toimintakykyä. Edita, 2005.
Znajdź pełny tekst źródła1962-, Russell Margot, ed. When the road turns: Inspirational stories about people with MS. Health Communications, 2001.
Znajdź pełny tekst źródłaCzęści książek na temat "MS – Multiple Sclerosis"
’t Hart, Bert A., S. Anwar Jagessar, Krista Haanstra, Yolanda S. Kap, and Jon D. Laman. "Modeling MS in Nonhuman Primates." In Multiple Sclerosis Immunology. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7953-6_14.
Pełny tekst źródłaGawlik, Barbara B., and David A. Hafler. "Regulatory T Cells in MS." In Multiple Sclerosis Immunology. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7953-6_2.
Pełny tekst źródłaFriedrich, Anke. "MS and Vaccinations." In The Multiple Sclerosis Companion. Springer Berlin Heidelberg, 2023. http://dx.doi.org/10.1007/978-3-662-67540-3_12.
Pełny tekst źródłaFriedrich, Anke. "Forest Fire MS." In The Multiple Sclerosis Companion. Springer Berlin Heidelberg, 2023. http://dx.doi.org/10.1007/978-3-662-67540-3_15.
Pełny tekst źródłaFreeman, Jennifer. "Rehabilitation in People with Progressive MS." In Progressive Multiple Sclerosis. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-65921-3_10.
Pełny tekst źródłaFriedrich, Anke. "How MS Is Treated." In The Multiple Sclerosis Companion. Springer Berlin Heidelberg, 2023. http://dx.doi.org/10.1007/978-3-662-67540-3_6.
Pełny tekst źródłaBull, Paul J. "The Impact of MS." In People with Multiple Sclerosis. Palgrave Macmillan UK, 2015. http://dx.doi.org/10.1057/9781137457066_6.
Pełny tekst źródłaAbrahamsson, Sofia, Miriam Mattoscio, and Paolo A. Muraro. "Haematopoietic Stem Cells for the Treatment of MS." In Multiple Sclerosis Immunology. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7953-6_19.
Pełny tekst źródłaHutchinson, Michael, and David P. J. Hunt. "Trials of Licenced RRMS DMTs in Progressive MS." In Progressive Multiple Sclerosis. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-65921-3_8.
Pełny tekst źródłaNicholas, R. S., A. Nandoskar, M. Hutchinson, and T. Friede. "Trials of Novel Therapies Specifically for Progressive MS." In Progressive Multiple Sclerosis. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-65921-3_9.
Pełny tekst źródłaStreszczenia konferencji na temat "MS – Multiple Sclerosis"
Sharabas, Youssef Hazem Mohamed Fathi, Yasmine Abou Ouf Hamed, and Zeinab Abd El Haliem Taha. "Multiple Sclerosis (MS) Classification and Detection." In 2024 Intelligent Methods, Systems, and Applications (IMSA). IEEE, 2024. http://dx.doi.org/10.1109/imsa61967.2024.10652740.
Pełny tekst źródłaMendanha, Serena, Keerthi Reddy Gudibandi, Koduru Hajarathaiah, Bharat Reddy Gudibandi, and Murali Krishna Enduri. "Comparative Analysis of Machine Learning Algorithm; for Conversion Predictors of Clinically Isolated Syndrome (CIS) to Multiple Sclerosis (MS)." In 2025 4th International Conference on Sentiment Analysis and Deep Learning (ICSADL). IEEE, 2025. https://doi.org/10.1109/icsadl65848.2025.10933208.
Pełny tekst źródłaGuerrera, Brittany, Samantha Farrow, Gloria Zeng, and Sally F. Shady. "Multiple Sclerosis Symptom Analyzer." In ASME 2016 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2016. http://dx.doi.org/10.1115/imece2016-66217.
Pełny tekst źródłaSilva, Diógenes Emanuel Dantas da, Leandro Cabral Moreira Guimarães, Maria Eduarda Medeiros Martins, et al. "Clinical aspects of multiple sclerosis in childhood." In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.642.
Pełny tekst źródłaKaminska, M., DA Trojan, D. Da Costa, et al. "Sleep-Disordered Breathing (SDB) and Fatigue in Multiple Sclerosis (MS)." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a2128.
Pełny tekst źródłaMorrison, Cecily, Robert Corish, and Abigail Sellen. "ASSESS MS: Supporting the Clinical Assessment of Multiple Sclerosis using Kinect." In 8th International Conference on Pervasive Computing Technologies for Healthcare. ICST, 2014. http://dx.doi.org/10.4108/icst.pervasivehealth.2014.255429.
Pełny tekst źródłaBrussell, Edward M., and Mike Dixon. "Spatial and Temporal Deficits in Multiple Sclerosis." In Noninvasive Assessment of the Visual System. Optica Publishing Group, 1987. http://dx.doi.org/10.1364/navs.1987.wb4.
Pełny tekst źródłaEkgi, Ziya, Muhammed Emin Ozean, Ayse Aralasmak, Emre Dandil, and Murat Cakiroglu. "Automatic computer-aided detection of Multiple Sclerosis (MS) lesions on MR images." In 2015 19th National Biomedical Engineering Meeting (BIYOMUT). IEEE, 2015. http://dx.doi.org/10.1109/biyomut.2015.7369443.
Pełny tekst źródłaZhong, Yi, Shouliang Qi, Yan Kang, David Utriainen, Wei Feng, and E. Mark Haacke. "The average cerebral perfusion in patients with multiple sclerosis (MS) using MRI." In 2012 International Conference on Information and Automation (ICIA). IEEE, 2012. http://dx.doi.org/10.1109/icinfa.2012.6246865.
Pełny tekst źródłaBenjamin, Jacobs, Waddingham Ed, Craner Matt, et al. "OPTIMISE-MS: real-world safety of disease-modifying therapies for multiple sclerosis." In Association of British Neurologists: Annual Meeting Abstracts 2023. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/jnnp-2023-abn.100.
Pełny tekst źródłaRaporty organizacyjne na temat "MS – Multiple Sclerosis"
Timm, Eliane, Julia Vieregg, and Ursula Wolf. Movement based mindfulness therapies in patients with multiple sclerosis – a systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.2.0102.
Pełny tekst źródłaMahmoudi, Farhad, Mahtab Mokarram, Sadegh Sabouhi, Sara Hashemi, Parastoo Saberi, and Hadi Zamanian. Application of digital health for improving medication adherence in MS patients. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.10.0058.
Pełny tekst źródłazhang, linlin, xihua liu, yuxiao chen, et al. Effect of exercise training in multiple sclerosis: a protocol for systematic reviews and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.3.0163.
Pełny tekst źródłaNourbakhsh, Bardia, Nisha Revirajan, Bridget Morris, et al. Comparing Medicines to Help Patients with Multiple Sclerosis Feel Less Fatigued -- The TRIUMPHANT-MS Study. Patient-Centered Outcomes Research Institute (PCORI), 2021. http://dx.doi.org/10.25302/06.2021.ms.151133689.
Pełny tekst źródłaEhde, Dawn, Kevin Alschuler, Mark Sullivan, et al. Does a Collaborative Care Program for Patients with Multiple Sclerosis Reduce Pain and Depression?—MS Care. Patient-Centered Outcomes Research Institute® (PCORI), 2020. http://dx.doi.org/10.25302/06.2020.ih.13046379.
Pełny tekst źródłaEhde, Dawn, Kevin Alschuler, Mark Sullivan, et al. Does a Collaborative Care Program for Patients With Multiple Sclerosis Reduce Pain and Depression?—MS CARE. Patient-Centered Outcomes Research Institute (PCORI), 2020. http://dx.doi.org/10.25302/04.2020.ih.13046379.
Pełny tekst źródłaSriram, Subramaniam. MALDI/Mass Spectrometry of Normal Appearing and Dystrophic Axons in Spinal Cord of Multiple Sclerosis (MS). Defense Technical Information Center, 2012. http://dx.doi.org/10.21236/ada582356.
Pełny tekst źródłaSriram, Subramaniam. MALDI/Mass Spectrometry of Normal Appearing" and Dystrophic Axons in Spinal Cord of Multiple Sclerosis (MS)". Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada592436.
Pełny tekst źródłaPiehl, Fredick, Anna Fogdell-Hahn, Jessica Smith, et al. Comparing the Safety and Effectiveness of Different Medicines to Treat Multiple Sclerosis – The COMBAT-MS Study. Patient-Centered Outcomes Research Institute (PCORI), 2023. http://dx.doi.org/10.25302/11.2023.ms.151133196.
Pełny tekst źródłaBraley, Tiffany, and Anna Kratz. Comparing the Effectiveness of Three Treatments for Reducing Fatigue among Patients with Multiple Sclerosis -- The COMBO-MS Trial. Patient-Centered Outcomes Research Institute (PCORI), 2023. http://dx.doi.org/10.25302/10.2023.ms.161036980.
Pełny tekst źródła